Form 4: Insider Sells 500 Shares of ANI Pharmaceuticals

Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, Inc., sold 500 shares of common stock on April 13, 2026, as part of a pre-arranged trading plan.

Summary

• Meredith Cook, the Senior Vice President, General Counsel & Secretary of ANI Pharmaceuticals, Inc., sold 500 shares of the company's common stock.
• The transaction occurred on April 13, 2026, and the shares were sold at a price of $77.95 per share.
• This sale was executed under a Rule 10b5-1 trading plan, which was adopted by the reporting person on September 15, 2025.
• Following this transaction, Meredith Cook beneficially owns 78,890 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider transaction executed under a pre-established trading plan, with no immediate indication of positive or negative company performance.

Negatives

• Insider selling can sometimes be perceived negatively by the market, although this sale was conducted under a pre-established trading plan.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it solely reports a past transaction.

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under Rule 10b5-1 plans, are common and often reflect pre-planned diversification or liquidity needs rather than a negative view of the company's prospects. However, the market often scrutinizes such transactions.

Stakeholder Impact

• Shareholders: The sale of 500 shares by a senior executive may lead to minor market speculation, though the Rule 10b5-1 plan mitigates concerns about insider trading based on material non-public information.

Key Dates

Keywords

ANI Pharmaceuticals, ANIP, Insider Trading, Form 4, Stock Sale, Rule 10b5-1, Meredith Cook